Key Market Indicators
**Bulgarian Insulin Imports to Hit $34 Million by 2028** SOFIA – Bulgaria's insulin imports are projected to reach $34 million by 2028, up from approximately $33 million in 2023. This marks a steady annual growth rate of 0.8% over the next five years. Since 2001, Bulgarian demand for insulin has shown a consistent year-on-year increase of 2.7%, reflecting the country's growing need for the essential diabetes medication. **Rising Exports** In parallel, Bulgaria's insulin exports are set to grow significantly. By 2028, exports are expected to reach nearly $4 million, up from around $3 million in 2023. This represents an average annual growth rate of 3.1%. Since the beginning of the millennium, Bulgaria's insulin supply has surged by 3.4% annually. As of 2023, Bulgaria ranked 22nd globally in insulin exports, with Australia slightly ahead at about $3 million. **Global Standings** In the global context, France, Italy, and China occupied the second, third, and fourth positions in insulin exports, respectively. This competitive landscape underscores Bulgaria's growing presence in the international insulin market, as it continues to scale up its production and export capabilities.
